An in vitro study examining the neutralizing ability of IgG and IgA from B cells of COVID-19 convalescent subjects found that dimeric IgA was much more effective than IgA monomers or IgG in neutralizing SARS-CoV-2 (79). Here, CD79A is linked to COVID-19.